Merighi S, Borea P, Varani K, Vincenzi F, Jacobson K, Gessi S
Curr Med Chem. 2021; 29(24):4138-4151.
PMID: 34844537
PMC: 9148371.
DOI: 10.2174/0929867328666211129122550.
Polis B, Karasik D, Samson A
Aging (Albany NY). 2021; 13(7):10770-10795.
PMID: 33811757
PMC: 8064158.
DOI: 10.18632/aging.202928.
Jacobson K, Gao Z, Matricon P, Eddy M, Carlsson J
Br J Pharmacol. 2020; 179(14):3496-3511.
PMID: 32424811
PMC: 9251831.
DOI: 10.1111/bph.15103.
Kirk K, Jacobson K
Bull Hist Chem. 2015; 39(2):150-165.
PMID: 26412957
PMC: 4581437.
Fredholm B, Jacobson K
Heterocycles. 2015; 79(1):73-83.
PMID: 26113768
PMC: 4477965.
DOI: 10.3987/COM-08-S(D)Memoire-2.
Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.
Ananthan S, Saini S, Zhou G, Hobrath J, Padmalayam I, Zhai L
J Med Chem. 2014; 57(16):7042-60.
PMID: 25126833
PMC: 4148173.
DOI: 10.1021/jm500801r.
Release of(14)C-adenine derivatives from cerebral cortical slices: Effect of phenytoin and phenobarbital.
Lewin E, Bleck V
Neurochem Res. 2013; 1(4):429-35.
PMID: 24271574
DOI: 10.1007/BF00966234.
Release of phosphodiesterase activator from particulate fractions of cerebellum and striatum by putative neurotransmitters.
Revuelta A, Uzunov P, Costa E
Neurochem Res. 2013; 1(2):217-27.
PMID: 24271344
DOI: 10.1007/BF00966112.
Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55.
Cheung T, Loriaux A, Weber S, Chandler K, Lenz J, Schaan R
J Pharmacol Exp Ther. 2013; 347(2):410-23.
PMID: 24018640
PMC: 3807071.
DOI: 10.1124/jpet.112.202911.
Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.
Luedtke R, Mishra Y, Wang Q, Griffin S, Bell-Horner C, Taylor M
ACS Chem Neurosci. 2012; 3(12):1050-62.
PMID: 23259040
PMC: 3526968.
DOI: 10.1021/cn300142q.
Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.
Michalski J, Kanaji N, Liu X, Nogel S, Wang X, Basma H
Am J Respir Cell Mol Biol. 2012; 47(6):729-37.
PMID: 23043089
PMC: 5459525.
DOI: 10.1165/rcmb.2012-0057OC.
Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain.
Tu Z, Li S, Xu J, Chu W, Jones L, Luedtke R
Nucl Med Biol. 2011; 38(5):725-39.
PMID: 21718948
PMC: 3128788.
DOI: 10.1016/j.nucmedbio.2011.01.002.
Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures.
Urbanska A, Sokolowska P, Woldan-Tambor A, Bieganska K, Brix B, Johren O
J Mol Neurosci. 2011; 46(1):10-7.
PMID: 21547533
PMC: 3260434.
DOI: 10.1007/s12031-011-9526-2.
Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound.
Vangveravong S, Zhang Z, Taylor M, Bearden M, Xu J, Cui J
Bioorg Med Chem. 2011; 19(11):3502-11.
PMID: 21536445
PMC: 3118479.
DOI: 10.1016/j.bmc.2011.04.021.
Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands.
Tu Z, Li S, Cui J, Xu J, Taylor M, Ho D
J Med Chem. 2011; 54(6):1555-64.
PMID: 21348515
PMC: 3066655.
DOI: 10.1021/jm101323b.
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626.
Vangveravong S, Taylor M, Xu J, Cui J, Calvin W, Babic S
Bioorg Med Chem. 2010; 18(14):5291-300.
PMID: 20542439
PMC: 2946321.
DOI: 10.1016/j.bmc.2010.05.052.
Lack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells.
Montgomery M, Bylund D
Br J Pharmacol. 2010; 159(4):820-30.
PMID: 20128806
PMC: 2829208.
DOI: 10.1111/j.1476-5381.2009.00584.x.
Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways.
Taylor M, Grundt P, Griffin S, Newman A, Luedtke R
Synapse. 2009; 64(3):251-66.
PMID: 19924694
PMC: 3821045.
DOI: 10.1002/syn.20725.
Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.
Kumar R, Riddle L, Griffin S, Chu W, Vangveravong S, Neisewander J
Neuropharmacology. 2009; 56(6-7):956-69.
PMID: 19371586
PMC: 4106465.
DOI: 10.1016/j.neuropharm.2009.01.019.
Effects of PACAP and VIP on cAMP-generating system and proliferation of C6 glioma cells.
Sokolowska P, Nowak J
J Mol Neurosci. 2008; 36(1-3):286-91.
PMID: 18491045
DOI: 10.1007/s12031-008-9071-9.
